InsiderTrades.com logo
Hao-Yuan Chuang net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Hao-Yuan Chuang Biography and Net Worth

CFO of Belite Bio

Mr. Hao-Yuan Chuang has served as the Chief Financial Officer of our Company since April 2020 and Director of Belite Bio since November 2021. Prior to joining Belite Bio, Mr. Chuang served as Chief Financial Officer of Lin BioScience, Inc. (TPEx: 6696), our ultimate controlling shareholder, Investment Director of Suning International Limited, and Portfolio Manager of The People’s Insurance Company (Group) of China Limited (HKG: 1339). Mr. Chuang received his MBA from Columbia University, London Business School, and the University of Hong Kong. Mr. Chuang is also a Chartered Financial Analyst and Financial Risk Manager.

What is Hao-Yuan Chuang's net worth?

The estimated net worth of Hao-Yuan Chuang is at least $15.52 million as of April 9th, 2026. Mr. Chuang owns 93,800 shares of Belite Bio stock worth more than $15,517,334 as of April 21st. This net worth approximation does not reflect any other assets that Mr. Chuang may own. Learn More about Hao-Yuan Chuang's net worth.

How do I contact Hao-Yuan Chuang?

The corporate mailing address for Mr. Chuang and other Belite Bio executives is , , . Belite Bio can also be reached via phone at 858-246-6240 and via email at [email protected]. Learn More on Hao-Yuan Chuang's contact information.

Has Hao-Yuan Chuang been buying or selling shares of Belite Bio?

During the last quarter, Hao-Yuan Chuang has sold $1,125,300.00 in Belite Bio stock. Most recently, Hao-Yuan Chuang sold 6,200 shares of the business's stock in a transaction on Thursday, April 9th. The shares were sold at an average price of $181.50, for a transaction totalling $1,125,300.00. Following the completion of the sale, the chief financial officer now directly owns 93,800 shares of the company's stock, valued at $17,024,700. Learn More on Hao-Yuan Chuang's trading history.

Who are Belite Bio's active insiders?

Belite Bio's insider roster includes Hao-Yuan Chuang (CFO), and Nathan Mata (Chief Scientific Officer). Learn More on Belite Bio's active insiders.

Are insiders buying or selling shares of Belite Bio?

In the last year, insiders at the sold shares 5 times. They sold a total of 18,500 shares worth more than $3,323,043.00. The most recent insider tranaction occured on April, 17th when insider Nathan L Mata sold 1,000 shares worth more than $161,630.00. Insiders at Belite Bio own 13.3% of the company. Learn More about insider trades at Belite Bio.

Information on this page was last updated on 4/17/2026.

Hao-Yuan Chuang Insider Trading History at Belite Bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/9/2026Sell6,200$181.50$1,125,300.0093,800View SEC Filing Icon  
See Full Table

Hao-Yuan Chuang Buying and Selling Activity at Belite Bio

This chart shows Hao-Yuan Chuang's buying and selling at Belite Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Belite Bio Company Overview

Belite Bio logo
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. The company's lead product candidate is LBS-008 (Tinlarebant), an orally administered once-a-day tablet for maintaining the health and integrity of retinal tissues in autosomal recessive Stargardt disease and geographic atrophy patients. It is also developing LBS-009, an anti-retinol binding protein 4 oral therapy that is in the preclinical development phase targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc is a subsidiary of Lin Bioscience International Ltd.
Read More

Today's Range

Now: $164.45
Low: $165.09
High: $165.09

50 Day Range

MA: $170.24
Low: $149.18
High: $190.30

2 Week Range

Now: $164.45
Low: $53.60
High: $200.00

Volume

1,549 shs

Average Volume

202,214 shs

Market Capitalization

$6.57 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A